
13 November 2024 | Featured
Shaping infant futures: ImmunoIVD & Thermo Fisher Scientific’s qPCR innovations

Discover how ImmunoIVD and Thermo Fisher Scientific are making an impact on newborn screening and clinical diagnostics by watching the video below. See how ImmunoIVD develops effective assays used by laboratories to screen for severe combined immunodeficiency and spinal muscular atrophy. With these serious conditions, early diagnosis and treatment are pivotal to the life outcomes … Continued
Read moreRead
More
News
14 September 2024
CHU Grenoble Alps welcomes French laboratories wishing to gain practical experience of the SPOT-it™ screening kit.
ImmunoIVD and its French distributor, AdGeniX, had the pleasure of training a team at CHU Grenoble Alpes in the use of SPOT-it™ assay for severe combined immunodeficiency (SCID) and Spinal Muscular Atrophy (SMA) newborn screening. The laboratory is now ready to accommodate other French laboratories wishing to gain hands-on experience with the SPOT-it™ Screening Kit. … Continued
Read more
13 August 2024
ImmunoIVD receives ISO14001 certification and A- Score on ESG rating
We’re happy to announce that ImmunoIVD AB has officially received the ISO14001 certification from Svensk Certifiering. This certificate is a formal recognition of our long-standing commitment to sustainable practices and our dedication to protecting the environment. We strive to not only improve lives by providing reliable newborn screening assays but also to do so in … Continued
Read more
Events
Events
23
March
23
March
13th ISNS European Regional Meeting in Luxembourg
Location
European Congress Center Luxembourg
Description
Join us in Luxembourg in 2025 at the “Newborn screening LIVE in the heart of Europe” meeting.
Interested in Our Products?